(HealthDay)—Preoperative placement of gastrostomy tubes (G-tubes) in patients with head and neck cancer yields cost savings, according to a study published online Nov. 13 in Head & Neck.
Dec 27, 2017
0
3
(HealthDay)—Certain clinical factors, including wound complications, are associated with reoperation and prolonged hospitalization in patients undergoing free tissue transfer (FTT) for reconstruction related to head and ...
Dec 4, 2017
0
0
Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition—which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment—are ...
Nov 30, 2017
0
0
A trial to test an experimental drug in patients with head and neck cancer launches in the UK today (Friday), through the Combinations Alliance – a joint initiative between Cancer Research UK and the Experimental Cancer ...
Nov 24, 2017
0
1
(HealthDay)—For patients with head and neck cancer, a multidisciplinary head and neck clinic model is associated with reduced treatment delay, according to a study published online Oct. 26 in JAMA Otolaryngology—Head ...
Oct 29, 2017
0
1
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. Researchers from ...
Oct 23, 2017
0
228
Surgeons at Penn Medicine are using a fluorescent dye that makes cancerous cells glow in hopes of identifying suspicious lymph nodes during head and neck cancer procedures. Led by Jason G. Newman, MD, FACS, an associate professor ...
Oct 10, 2017
0
26
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers ...
Sep 21, 2017
0
2
Doctors at Penn Medicine have become the first in the world to treat a patient with a new treatment platform designed to streamline the way therapeutic radiation is delivered to cancer patients. The Varian Halcyon system ...
Sep 21, 2017
0
0
Immunotherapy with the checkpoint inhibitor pembrolizumab may be a better option than standard treatments for patients whose head and neck cancer has spread, or recurred after an initial round of chemotherapy, according to ...
Sep 11, 2017
0
0
